Conflict of interest: Dennis W.T. Nilsen, MD, PhD: None; Roxana Mehran, MD: Research Grants (institutional)—BMS/Sanofi, The Medicines Co., Lilly/Daiichi Sankyo. Advisory Board—Regado. Consultant—AstraZeneca, Abbott, Johnson & Johnson, Merck Sharp & Dohme, Maya Medical; Roland Wu, MD: None; Jan E. Nordrehaug, MD, PhD: None; Bruce B. Brodie, MD: None; Bernhard Witzenbichler, MD: Lecture Fees (modest) from Boston Scientific and the Medicines Company; Jennifer Yu, MBBS: None; Eugenia Nikolsky, MD: None; Martin Fahy, MSc: None; Gregg W. Stone, MD: Consultant to Medtronic, Boston Scientific, Abbott Vascular and the Medicines Company.
Coronary Artery Disease
Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: Findings from the HORIZONS-AMI trial
Article first published online: 26 JUN 2013
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 82, Issue 4, pages 594–601, 1 October 2013
How to Cite
Nilsen, D. W.T., Mehran, R., Wu, R. S., Yu, J., Nordrehaug, J. E., Brodie, B. R., Witzenbichler, B., Nikolsky, E., Fahy, M. and Stone, G. W. (2013), Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: Findings from the HORIZONS-AMI trial. Cathet. Cardiovasc. Intervent., 82: 594–601. doi: 10.1002/ccd.24705
- Issue published online: 23 SEP 2013
- Article first published online: 26 JUN 2013
- Accepted manuscript online: 16 OCT 2012 10:47AM EST
- Manuscript Accepted: 7 OCT 2012
- Manuscript Received: 11 SEP 2012